Tissue Tek Sakura Finetek Torrance Ca

Lab Reagents

Human IgG antibody Laboratories manufactures the tissue tek sakura finetek torrance ca reagents distributed by Genprice. The Tissue Tek Sakura Finetek Torrance Ca reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact sakura tissue tek. Other Tissue products are available in stock. Specificity: Tissue Category: Tek Group: Sakura Finetek

Sakura Finetek information

Anti-TEK antibody

STJ29302 100 µl
EUR 332.4
Description: This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known.

Anti-TEK Antibody

STJ503257 100 µg
EUR 571.2

Anti-TEK Antibody

STJ503258 100 µg
EUR 571.2

AN3 CA

C0026002 One Frozen vial
EUR 651.6

CA 074

A1926-1 1 mg
EUR 177.6
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-10 10 mg
EUR 582
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-25 25 mg
EUR 895.2
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5 5 mg
EUR 373.2
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5.1 10 mM (in 1mL DMSO)
EUR 518.4
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-S Evaluation Sample
EUR 97.2
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA-1001

B2669-25 25mg
EUR 709.2

CA-1001

B2669-5 5mg
EUR 223.2

CA-074

B2971-1 1 mg
EUR 235.2

CA-074

B2971-5 5 mg
EUR 764.4

CA-074

HY-103350 10mg
EUR 704.4

CA-5f

HY-112698 5mg
EUR 211.2

CA-1/ Rat CA- 1 ELISA Kit

ELA-E1799r 96 Tests
EUR 1063.2